The pharmacokinetics, safety, and tolerability of four topical lidocaine patches 5% continuously applied for 72 hours and changed every 12 or 24 hours were examined. In this randomized, prospective, ...
Burlington, Ontario--(Newsfile Corp. - December 5, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotechnology company, is pleased to announce that it has ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (ANDA) approval from ...
Esophagogastroduodenoscopy (EGD) is a common diagnostic and therapeutic technique with a low complication risk, but which causes considerable patient anxiety. Sedation during endoscopy by intravenous ...
Sorrento Therapeutics (NASDAQ:SRNE) announces that majority-owned subsidiary SCILEX Pharmaceuticals has resubmitted a New Drug Application (NDA) seeking approval for ZTlido (lidocaine patch 1.8%) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback